Foresite Capital Management V, LLC
Annual return '25
+16.0%
SPY '25
+17.7%
Alpha
-1.7ptsvs SPY
Invested
$271M
Holdings
9
Trades YTD
0
Performance · Fund vs SPY
Cumulative return · quarterly snapshotsCoverage 97%. 4 quarters of 2025 measured against SPY adj-close benchmark.
Top holdings · current snapshot
Source: 13F-HR01
$ALMS
ALUMIS INC.
Q4 2025: Exited (was 5.78M shares)
47.9%
02
$CGON
CG Oncology, Inc.
Q4 2025: Exited (was 1.00M shares)
25.1%
03
$IRON
Disc Medicine, Inc.
Q4 2025: Exited (was 299.1k shares)
8.8%
04
$HIMS
Hims & Hers Health, Inc.
Q4 2025: Exited (was 273.2k shares)
5.7%
05
$EIKN
Eikon Therapeutics, Inc.
Held since at least Q1 2024
5.1%
06
$LYEL
Lyell Immunopharma, Inc.
Q4 2025: Exited (was 477.1k shares)
3.5%
07
$PHVS
Pharvaris N.V.
Held since at least Q1 2024
2.0%
08
$NRIX
Nurix Therapeutics, Inc.
Held since at least Q1 2024
1.5%
09
$MAZE
Maze Therapeutics, Inc.
Q4 2025: Exited (was 86.3k shares)
0.3%
Recent trades · Last 90 days
No Form 4 / 13D / 13G trade events on file in the recent window. 13F filers report position snapshots quarterly rather than per-trade events, so this section is most useful for managers who also file Form 4 or 13D/G.
Convergence · Pattern Engine ships in v1.1
30-day windowIn development
Convergence participation lands with the Pattern Engine.
Once the Pattern Engine ships, this section will list every active convergence event this fund is named in — with the other named funds, the Congress members on the same name, and combined position size.
Source data: SEC EDGAR · 13F-HR filings · Performance through 2025-12-31 · Last refreshed 10:20 UTC.